CEO and Chairman of Adaptive Biotechnologies Corp (30-Year Financial, Insider Trades) Chad M Robins (insider trades) sold 15,000 shares of ADPT on 03/19/2021 at an average price of $42.89 a share. The total sale was $643,350.
Adaptive Biotechnologies Corp has a market cap of $5.83 billion; its shares were traded at around $41.890000 with and P/S ratio of 56.07.
CEO Recent Trades:
- CEO and Chairman Chad M Robins sold 15,000 shares of ADPT stock on 03/19/2021 at the average price of $42.89. The price of the stock has decreased by 2.33% since.
CFO Recent Trades:
- CFO Chad M Cohen sold 10,000 shares of ADPT stock on 03/10/2021 at the average price of $42.54. The price of the stock has decreased by 1.53% since.
- CFO Chad M Cohen sold 10,000 shares of ADPT stock on 03/09/2021 at the average price of $40.24. The price of the stock has increased by 4.1% since.
Directors and Officers Recent Trades:
- SVP, Diagnostics, immunoSEQ Dx Jyoti Palaniappan sold 16,052 shares of ADPT stock on 03/18/2021 at the average price of $43.58. The price of the stock has decreased by 3.88% since.
- Director Michelle Renee Griffin sold 6,000 shares of ADPT stock on 03/16/2021 at the average price of $43.06. The price of the stock has decreased by 2.72% since.
- Chief Business Development Off Sharon Benzeno sold 1,354 shares of ADPT stock on 03/15/2021 at the average price of $41.69. The price of the stock has increased by 0.48% since.
- Chief People Officer Francis Lo sold 2,000 shares of ADPT stock on 03/15/2021 at the average price of $41.83. The price of the stock has increased by 0.14% since.
- David E. Goel sold 806,000 shares of ADPT stock on 03/10/2021 at the average price of $39.99. The price of the stock has increased by 4.75% since.
For the complete insider trading history of ADPT, click here
.
